DermTech, Inc.
DMTKQ
$0.00
$0.000.00%
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.71% | 5.36% | -2.20% | -0.86% | 9.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.71% | 5.36% | -2.20% | -0.86% | 9.55% |
| Cost of Revenue | 1.37% | 8.28% | 9.77% | 16.23% | 16.69% |
| Gross Profit | 858.99% | -57.34% | -146.10% | -158.87% | -84.83% |
| SG&A Expenses | -24.58% | -12.12% | -2.15% | 14.80% | 31.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.78% | -14.43% | -6.60% | 8.27% | 25.27% |
| Operating Income | 27.76% | 16.86% | 7.16% | -9.48% | -27.44% |
| Income Before Tax | 23.94% | 13.54% | 3.92% | -13.01% | -26.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 23.94% | 13.54% | 3.92% | -13.01% | -26.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.94% | 13.54% | 3.92% | -13.01% | -26.21% |
| EBIT | 27.76% | 16.86% | 7.16% | -9.48% | -27.44% |
| EBITDA | 28.27% | 17.26% | 7.52% | -9.18% | -27.18% |
| EPS Basic | 31.13% | 19.38% | 8.34% | -9.79% | -23.64% |
| Normalized Basic EPS | 35.57% | 23.83% | 12.86% | -4.92% | -23.64% |
| EPS Diluted | 30.98% | 19.36% | 8.34% | -9.84% | -23.76% |
| Normalized Diluted EPS | 35.57% | 23.83% | 12.86% | -4.92% | -23.64% |
| Average Basic Shares Outstanding | 11.42% | 8.63% | 5.68% | 2.95% | 2.26% |
| Average Diluted Shares Outstanding | 11.42% | 8.63% | 5.68% | 2.95% | 2.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |